..............page:2041-2046+2051
..............page:2047-2051
..............page:2052-2059
..............page:2060-2064+2072
General pharmacology of the new Rho kinase inhibitor DL0805-2
CHEN Yu-cai;ZHANG Hui-fang;LIN Yi-huang;WANG Dan-shu;WANG Rui;JIAO Xiao-zhen;XIE Ping;FANG Lian-hua;DU Guan-hua;Beijing Key Laboratory of Drug Targets Identification and Drug Screening;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;
..............page:2065-2072
..............page:2073-2076
..............page:2077-2080+2084
..............page:2081-2084
..............page:2085-2090+2104
..............page:2091-2095
..............page:2096-2100
..............page:2101-2104
..............page:2105-2109
..............page:2110-2114+2121
..............page:2115-2121
..............page:2122-2127
..............page:2128-2133
..............page:2134-2138+2141
..............page:2139-2141
..............page:2142-2146+2152
..............page:2147-2152
..............page:2153-2156
..............page:2157-2160